Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
23 studies found for:    "Muscular Dystrophies, Limb-Girdle"
Show Display Options
RSS Create an RSS feed from your search for:
"Muscular Dystrophies, Limb-Girdle"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Limb Girdle Muscular Dystrophy (LGMD) Natural History
Condition: Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)
Intervention:
2 Completed Cell Therapy in Limb Girdle Muscular Dystrophy
Condition: Limb Girdle Muscular Dystrophy
Intervention: Biological: Stem Cell
3 Completed Stem Cell Therapy in Limb Girdle Muscular Dystrophy
Condition: Limb Girdle Muscular Dystrophy
Intervention: Biological: Autologous bone marrow mononuclear cell transplantation
4 Active, not recruiting Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
Condition: Limb-Girdle Muscular Dystrophy
Intervention:
5 Completed Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
Conditions: Limb Girdle Muscular Dystrophy Type 2C;   Gamma-sarcoglycanopathy
Intervention: Biological: AAV1-gamma-sarcoglycan vector injection
6 Completed Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I
Conditions: Becker Muscular Dystrophy;   Limb-Girdle Muscular Dystrophy Type 2I
Intervention:
7 Completed Evaluation of Limb-Girdle Muscular Dystrophy
Conditions: Becker Muscular Dystrophy;   Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency);   Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency);   Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)
Intervention:
8 Active, not recruiting MRI on Persons With Mutations in POMT2 Gene (LGMD2N)
Condition: Limb-girdle Muscular Dystrophy
Intervention:
9 Completed MRI and Muscle Involvement in Patients With Mutations in GMPPB
Condition: Limb-girdle Muscular Dystrophy
Intervention:
10 Enrolling by invitation Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA
Condition: Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
Intervention: Drug: scAAVrh74.tMCK.hSGCA
11 Completed Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
Condition: Muscular Dystrophies
Interventions: Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- First cohort;   Genetic: Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- Second cohort
12 Completed The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
Conditions: Limb-Girdle Muscular Dystrophies;   Facioscapulohumeral Muscular Dystrophy
Interventions: Biological: ATYR1940;   Biological: Placebo
13 Enrolling by invitation Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy
Conditions: Facioscapulohumeral Muscular Dystrophy;   Limb Girdle Muscular Dystrophy
Intervention: Drug: ATYR1940
14 Enrolling by invitation Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies
Conditions: Duchenne Muscular Dystrophy;   Becker Muscular Dystrophy;   Limb Girdle Muscular Dystrophy
Intervention: Drug: Coenzyme Q10 and Lisinopril
15 Completed Cardiac Magnetic Resonance in Children With Muscular Dystrophy
Conditions: Duchenne Muscular Dystrophy;   Becker Muscular Dystrophy;   Limb Girdle Muscular Dystrophy
Intervention:
16 Completed Cardiac Outcome Measures in Children With Muscular Dystrophy
Conditions: Duchenne Muscular Dystrophy;   Becker Muscular Dystrophy;   Limb Girdle Muscular Dystrophy
Intervention:
17 Completed Study Evaluating MYO-029 in Adult Muscular Dystrophy
Conditions: Becker Muscular Dystrophy;   Facioscapulohumeral Muscular Dystrophy;   Limb-Girdle Muscular Dystrophy
Intervention: Drug: MYO-029
18 Recruiting rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies
Condition: Dysferlinopathy
Intervention: Drug: rAAVrh74.MHCK7.DYSF.DV
19 Completed
Has Results
Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy
Conditions: Muscular Dystrophies;   Duchenne Muscular Dystrophy;   Becker Muscular Dystrophy;   Limb-Girdle Muscular Dystrophy
Intervention: Other: Retrograde high pressure transvenous perfusion with normal saline
20 Completed Deflazacort in Dysferlinopathies
Conditions: LGMD2B;   Miyoshi Myopathy;   Dysferlinopathy
Interventions: Drug: deflazacort;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.